Tarsus Pharmaceuticals Inc. (TARS): Price and Financial Metrics
TARS Price/Volume Stats
| Current price | $44.08 | 52-week high | $57.28 |
| Prev. close | $42.65 | 52-week low | $20.08 |
| Day low | $40.28 | Volume | 811,500 |
| Day high | $44.26 | Avg. volume | 672,400 |
| 50-day MA | $46.76 | Dividend yield | N/A |
| 200-day MA | $44.53 | Market Cap | 1.85B |
TARS Stock Price Chart Interactive Chart >
Tarsus Pharmaceuticals Inc. (TARS) Company Bio
Tarsus is a clinical-stage biopharmaceutical company headquartered in Irvine, California. Tarsus was founded in 2017 to bring innovative therapies to a range of diseases in need of better solutions, starting with Demodex blepharitis and eye care.
TARS Latest News Stream
| Event/Time | News Detail | ||||||||
|---|---|---|---|---|---|---|---|---|---|
| Loading, please wait... | |||||||||
TARS Price Returns
| 1-mo | -6.91% |
| 3-mo | -5.14% |
| 6-mo | -14.89% |
| 1-year | 36.51% |
| 3-year | 206.11% |
| 5-year | N/A |
| YTD | -20.39% |
| 2024 | 173.43% |
| 2023 | 38.13% |
| 2022 | -34.84% |
| 2021 | -45.56% |
| 2020 | N/A |